Filing Details

Accession Number:
0001209191-22-045511
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-11 20:28:52
Reporting Period:
2022-08-09
Accepted Time:
2022-08-11 20:28:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082038 Durect Corp DRRX Pharmaceutical Preparations (2834) 943297098
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1503147 J Gail Maderis C/O Durect Corporation
10260 Bubb Road
Cupertino CA 95014
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-09 70,307 $0.64 70,307 No 4 P Indirect By Gail J. Maderis Revocable Trust dtd 04-08-2013 Gail Maderis TTEE
Common Stock Acquisiton 2022-08-10 79,693 $0.69 150,000 No 4 P Indirect By Gail J. Maderis Revocable Trust dtd 04-08-2013 Gail Maderis TTEE
Common Stock Acquisiton 2022-08-11 24,796 $0.70 174,796 No 4 P Indirect By Gail J. Maderis Revocable Trust dtd 04-08-2013 Gail Maderis TTEE
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Gail J. Maderis Revocable Trust dtd 04-08-2013 Gail Maderis TTEE
No 4 P Indirect By Gail J. Maderis Revocable Trust dtd 04-08-2013 Gail Maderis TTEE
No 4 P Indirect By Gail J. Maderis Revocable Trust dtd 04-08-2013 Gail Maderis TTEE
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.6103 to $0.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.6726 to $0.69 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.69 to $0.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.